𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines

✍ Scribed by Ken Kawamoto; Hiroshi Hirata; Nobuyuki Kikuno; Yuichiro Tanaka; Masayuki Nakagawa; Rajvir Dahiya

Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
680 KB
Volume
123
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Secreted frizzled‐related protein 2 (sFRP2) is a negative modulator of the Wingless‐type (Wnt) signaling pathway, and shown to be inactivated in renal cell carcinoma (RCC). However, the molecular mechanism of silencing of sFRP2 is not fully understood. Our study was designed to elucidate the silencing mechanism of sFRP2 in RCC. Expression of sFRP2 was examined in 20 pairs of primary cancers by immunohistochemistry. Kidney cell lines (HK‐2, Caki‐1, Caki‐2, A‐498 and ACHN) were analyzed for sFRP2 expression using real‐time RT‐PCR and Western blotting. The methylation status at 46 CpG sites of the 2 CpG islands in the sFRP2 promoter was characterized by bisulfite DNA sequencing. Histone modifications were assessed by chromatin immunoprecipitation (ChIP) assay using antibodies against AcH3, AcH4, H3K4 and H3K9. sFRP2 was frequently repressed in primary cancers and in RCC cells. The majority of sFRP2 negative cells had a methylated promoter. Meanwhile, sFRP2 expression was repressed by a hypomethylated promoter in Caki‐1 cells, and these cells had a repressive histone modification at the promoter. In Caki‐1 cells, sFRP2 was reactivated by trichostatin A (TSA). Repressive histone modifications were also observed in RCC cells with hypermethylated promoters, but sFRP2 was reactivated only by 5‐aza‐2′‐deoxycytidine (DAC) and not by TSA. However, the activation of the silenced sFRP2 gene could be achieved in all cells using a combination of DAC and TSA. This is the first report indicating that aberrant DNA methylation and histone modifications work together to silence the sFRP2 gene in RCC cells. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Wnt antagonist DKK1 acts as a tumor supp
Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma
✍ Hiroshi Hirata; Yuji Hinoda; Koichi Nakajima; Ken Kawamoto; Nobuyuki Kikuno; Koj 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 747 KB

## Abstract The functional significance of Wnt antagonist __DKK1__ has not been investigated in renal cell carcinoma (RCC). Therefore, we hypothesized that __DKK1__ may be a tumor suppressor gene and is epigenetically silenced, thus decreased __DKK1__ may cause progression of RCC. To assess the fun

DNA methylation-mediated silencing of no
DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines
✍ Mitsutoshi Kadowaki; Hiroki Yoshioka; Hideki Kamitani; Takashi Watanabe; Paul A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 757 KB

## Abstract Nonsteroidal anti‐inflammatory drug‐activated gene, __NAG‐1__, a transforming growth factor‐β member, is involved in tumor progression and development. The association between NAG‐1 expression and development and progression of glioma has not been well defined. Glioblastoma cell lines h

Activation of the MN/CA9 gene is associa
Activation of the MN/CA9 gene is associated with hypomethylation in human renal cell carcinoma cell lines
✍ Masaki Cho; Karin Grabmaier; Yoshiteru Kitahori; Yoshio Hiasa; Yoshinori Nakagaw 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

The MN/CA9 (G250) gene expressed in the normal alimentary tract in a tissue-specific manner is often activated in renal cell carcinomas. To cast light on the activation mechanism, we examined the methylation status of this gene in seven human renal cell carcinoma cell lines and three normal kidney t